• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性心力衰竭患者报告结局变化与后续临床事件的关系:HF-ACTION 的见解。

Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION.

机构信息

Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.

Duke Clinical Research Institute, Durham, NC, USA.

出版信息

Eur J Heart Fail. 2019 Jan;21(1):63-70. doi: 10.1002/ejhf.1299. Epub 2018 Aug 31.

DOI:10.1002/ejhf.1299
PMID:30168635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6333485/
Abstract

AIMS

A 5-point change in the Kansas City Cardiomyopathy Questionnaire (KCCQ) is commonly considered to be a clinically significant difference in health status in patients with heart failure. We evaluated how the magnitude of change relates to subsequent clinical outcomes.

METHODS AND RESULTS

Using data from the HF-ACTION trial of exercise training in chronic heart failure (n = 2331), we used multivariable Cox regression with piecewise linear splines to examine the relationship between change in KCCQ overall summary score from baseline to 3 months (range 0-100; higher scores reflect better health status) and subsequent all-cause mortality/hospitalization. Among 2038 patients with KCCQ data at the 3-month visit, KCCQ scores increased from baseline by ≥5 points for 45%, scores decreased by ≥5 points for 23%, and scores changed by <5 points for the remaining 32% of patients. There was a non-linear relationship between change in KCCQ and outcomes. Worsening health status was associated with increased all-cause mortality/hospitalization (adjusted hazard ratio 1.07 per 5-point KCCQ decline; 95% confidence interval 1.03-1.12; P < 0.001). In contrast, improving health status, up to an 8-point increase in KCCQ, was associated with decreased all-cause mortality/hospitalization (adjusted hazard ratio 0.93 per 5-point increase; 95% confidence interval 0.90-0.97; P < 0.001). Additional improvements in health status beyond an 8-point increase in KCCQ was not associated with all-cause death or hospitalization (P = 0.42).

CONCLUSION

In patients with heart failure, small changes in KCCQ are associated with changing future risk, but more research will be necessary to understand how different magnitudes of improving health status affect outcomes.

摘要

目的

堪萨斯城心肌病问卷(KCCQ)的 5 分变化通常被认为是心力衰竭患者健康状况的临床显著差异。我们评估了变化幅度与随后临床结局的关系。

方法和结果

使用来自慢性心力衰竭运动训练 HF-ACTION 试验的数据(n=2331),我们使用多变量 Cox 回归与分段线性样条来检查从基线到 3 个月时 KCCQ 总评分变化(范围 0-100;得分越高表示健康状况越好)与随后的全因死亡率/住院之间的关系。在 2038 名在 3 个月就诊时具有 KCCQ 数据的患者中,KCCQ 评分≥5 分的患者增加了 45%,评分下降≥5 分的患者占 23%,而其余 32%的患者评分变化<5 分。KCCQ 变化与结局之间存在非线性关系。健康状况恶化与全因死亡率/住院增加相关(调整后的危险比为 KCCQ 每下降 5 分增加 1.07;95%置信区间为 1.03-1.12;P<0.001)。相比之下,健康状况改善,KCCQ 增加 8 分,与全因死亡率/住院减少相关(调整后的危险比为 KCCQ 每增加 5 分降低 0.93;95%置信区间为 0.90-0.97;P<0.001)。KCCQ 增加超过 8 分后健康状况的进一步改善与全因死亡或住院无关(P=0.42)。

结论

在心力衰竭患者中,KCCQ 的微小变化与未来风险的变化相关,但需要进一步研究以了解健康状况改善的不同幅度如何影响结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db28/6333485/994b78215300/nihms-983542-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db28/6333485/50d2fd9e29eb/nihms-983542-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db28/6333485/bbfb91316964/nihms-983542-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db28/6333485/994b78215300/nihms-983542-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db28/6333485/50d2fd9e29eb/nihms-983542-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db28/6333485/bbfb91316964/nihms-983542-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db28/6333485/994b78215300/nihms-983542-f0003.jpg

相似文献

1
Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION.慢性心力衰竭患者报告结局变化与后续临床事件的关系:HF-ACTION 的见解。
Eur J Heart Fail. 2019 Jan;21(1):63-70. doi: 10.1002/ejhf.1299. Epub 2018 Aug 31.
2
Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection Fraction: A Secondary Analysis of 2 Randomized Clinical Trials.连续堪萨斯城心肌病问卷评估与射血分数保留和降低的心衰患者死亡和住院的相关性:两项随机临床试验的二次分析。
JAMA Cardiol. 2017 Dec 1;2(12):1315-1321. doi: 10.1001/jamacardio.2017.3983.
3
Comparison of the Kansas City Cardiomyopathy Questionnaire and Minnesota Living With Heart Failure Questionnaire in Predicting Heart Failure Outcomes.堪萨斯城心肌病问卷和明尼苏达州心力衰竭生活质量问卷在预测心力衰竭结局方面的比较。
Am J Cardiol. 2019 Mar 1;123(5):807-812. doi: 10.1016/j.amjcard.2018.11.037. Epub 2018 Dec 4.
4
Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.在射血分数降低的门诊心力衰竭患者中,地高辛的普遍使用及其随后的死亡或住院风险-来自心力衰竭:一项控制试验调查运动训练结果(HF-ACTION)的随机对照试验的结果。
Am Heart J. 2018 May;199:97-104. doi: 10.1016/j.ahj.2018.02.004. Epub 2018 Feb 11.
5
Health Status Changes and Outcomes in Patients With Heart Failure and Mitral Regurgitation: COAPT Trial.心力衰竭合并二尖瓣反流患者的健康状况变化和结局:COAPT 试验。
J Am Coll Cardiol. 2020 May 5;75(17):2099-2106. doi: 10.1016/j.jacc.2020.03.002. Epub 2020 Mar 16.
6
Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction.纽约心脏协会心功能分级与射血分数降低的心力衰竭患者报告结局的比较。
JAMA Cardiol. 2021 May 1;6(5):522-531. doi: 10.1001/jamacardio.2021.0372.
7
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.达格列净对射血分数降低的心力衰竭患者症状、功能和生活质量的影响:来自 DAPA-HF 试验的结果。
Circulation. 2020 Jan 14;141(2):90-99. doi: 10.1161/CIRCULATIONAHA.119.044138. Epub 2019 Nov 17.
8
Practical Application of Patient-Reported Health Status Measures for Transcatheter Valve Therapies: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.患者报告的健康状况测量指标在经导管瓣膜治疗中的实际应用:来自胸外科医师协会/美国心脏病学会经导管瓣膜治疗注册研究的见解
Circ Cardiovasc Qual Outcomes. 2021 Mar;14(3):e007187. doi: 10.1161/CIRCOUTCOMES.120.007187. Epub 2021 Feb 18.
9
Minimal clinically important difference in quality of life scores for patients with heart failure and reduced ejection fraction.心力衰竭和射血分数降低患者生活质量评分的最小临床重要差异。
Eur J Heart Fail. 2020 Jun;22(6):999-1005. doi: 10.1002/ejhf.1810. Epub 2020 Apr 2.
10
Health status identifies heart failure outpatients at risk for hospitalization or death.健康状况可识别出有住院或死亡风险的心力衰竭门诊患者。
J Am Coll Cardiol. 2006 Feb 21;47(4):752-6. doi: 10.1016/j.jacc.2005.11.021. Epub 2006 Jan 26.

引用本文的文献

1
Prognostic value of quality of life and functional status in patients with heart failure: a systematic review and meta-analysis.心力衰竭患者生活质量和功能状态的预后价值:一项系统评价和荟萃分析。
Egypt Heart J. 2024 Aug 5;76(1):97. doi: 10.1186/s43044-024-00532-z.
2
Global epidemiology of heart failure.心力衰竭的全球流行病学。
Nat Rev Cardiol. 2024 Oct;21(10):717-734. doi: 10.1038/s41569-024-01046-6. Epub 2024 Jun 26.
3
Is Sacubitril/Valsartan a Superior Agent in Heart Failure With Reduced Ejection Fraction? A Review of Randomized Comparative Trials.

本文引用的文献

1
Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection Fraction: A Secondary Analysis of 2 Randomized Clinical Trials.连续堪萨斯城心肌病问卷评估与射血分数保留和降低的心衰患者死亡和住院的相关性:两项随机临床试验的二次分析。
JAMA Cardiol. 2017 Dec 1;2(12):1315-1321. doi: 10.1001/jamacardio.2017.3983.
2
Quantifying clinical change: discrepancies between patients' and providers' perspectives.量化临床变化:患者与医疗服务提供者观点之间的差异。
Qual Life Res. 2016 Sep;25(9):2213-20. doi: 10.1007/s11136-016-1267-9. Epub 2016 Mar 19.
3
沙库巴曲缬沙坦在射血分数降低的心力衰竭中是一种更优药物吗?随机对照试验综述
Hosp Pharm. 2024 Jun;59(3):282-287. doi: 10.1177/00185787231212619. Epub 2023 Dec 6.
4
New York Heart Association Class and Kansas City Cardiomyopathy Questionnaire in Acute Heart Failure.纽约心脏协会心功能分级和堪萨斯城心肌病问卷在急性心力衰竭中的应用。
JAMA Netw Open. 2023 Oct 2;6(10):e2339458. doi: 10.1001/jamanetworkopen.2023.39458.
5
Changing health related quality of life and outcomes in heart failure by age, sex and subtype.心力衰竭患者健康相关生活质量及预后随年龄、性别和亚型的变化情况
EClinicalMedicine. 2023 Sep 14;64:102217. doi: 10.1016/j.eclinm.2023.102217. eCollection 2023 Oct.
6
Patients' preferences regarding the digital capturing of patient-reported outcomes: planning the future follow-up in a prospective heart failure registry.患者对患者报告结局的数字采集的偏好:规划前瞻性心力衰竭登记中的未来随访
Eur Heart J Digit Health. 2021 Aug 17;2(4):695-698. doi: 10.1093/ehjdh/ztab074. eCollection 2021 Dec.
7
Machine learning models in heart failure with mildly reduced ejection fraction patients.射血分数轻度降低的心力衰竭患者的机器学习模型
Front Cardiovasc Med. 2022 Nov 30;9:1042139. doi: 10.3389/fcvm.2022.1042139. eCollection 2022.
8
Effects of continuous aerobic training associated with resistance training on maximal and submaximal exercise tolerance, fatigue, and quality of life of patients post-COVID-19.有氧运动联合抗阻运动对新冠后患者最大和次最大运动耐量、疲劳和生活质量的影响。
Physiother Res Int. 2023 Jan;28(1):e1972. doi: 10.1002/pri.1972. Epub 2022 Sep 11.
9
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.达格列净与纽约心脏协会心功能分级在射血分数轻度降低或保留的心力衰竭中的应用:DELIVER 试验。
Eur J Heart Fail. 2022 Oct;24(10):1892-1901. doi: 10.1002/ejhf.2652. Epub 2022 Aug 27.
10
Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?钠-葡萄糖共转运蛋白 2 抑制剂能否改善慢性心力衰竭患者的运动不耐受?
Int J Mol Sci. 2022 Aug 3;23(15):8631. doi: 10.3390/ijms23158631.
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
血管紧张素-脑啡肽酶抑制剂与依那普利治疗心力衰竭的比较。
N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.
4
Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.堪萨斯城心肌病问卷在射血分数保留和降低的心衰患者中的可比表现。
Circ Heart Fail. 2013 Nov;6(6):1139-46. doi: 10.1161/CIRCHEARTFAILURE.113.000359. Epub 2013 Oct 15.
5
Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure.心脏再同步化治疗与有轻微症状心力衰竭患者的生活质量。
J Am Coll Cardiol. 2012 Nov 6;60(19):1940-4. doi: 10.1016/j.jacc.2012.06.054. Epub 2012 Oct 10.
6
Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure.心力衰竭门诊患者报告的健康状况和功能能力变化之间的关系。
Am Heart J. 2012 Jan;163(1):88-94.e3. doi: 10.1016/j.ahj.2011.09.027.
7
Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model.与收缩性心力衰竭伴慢性心力衰竭患者发病率和死亡率相关的因素:HF-ACTION 预测风险评分模型。
Circ Heart Fail. 2012 Jan;5(1):63-71. doi: 10.1161/CIRCHEARTFAILURE.111.963462. Epub 2011 Nov 23.
8
Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.依伐布雷定降低慢性心力衰竭患者心率和健康相关生活质量:SHIFT 研究结果。
Eur Heart J. 2011 Oct;32(19):2395-404. doi: 10.1093/eurheartj/ehr343. Epub 2011 Aug 29.
9
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.无线肺动脉血流动力学监测在慢性心力衰竭中的应用:一项随机对照试验。
Lancet. 2011 Feb 19;377(9766):658-66. doi: 10.1016/S0140-6736(11)60101-3.
10
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial.运动训练对慢性心力衰竭患者健康状况的影响:心力衰竭:一项改善临床结局的长期运动训练随机对照试验
JAMA. 2009 Apr 8;301(14):1451-9. doi: 10.1001/jama.2009.457.